BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 18171345)

  • 21. [MicroRNA profiling in patients with hepatocellular carcinoma].
    Wang CX; Song W; Li ZJ; Song B; Wu DH; Sun AM; Chen LH
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):976-7. PubMed ID: 20501372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cloning and characterization of a novel gene, DRH1, down-regulated in advanced human hepatocellular carcinoma.
    Yamamoto Y; Sakamoto M; Fujii G; Kanetaka K; Asaka M; Hirohashi S
    Clin Cancer Res; 2001 Feb; 7(2):297-303. PubMed ID: 11234883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of DNA repair genes in active cirrhosis associated with hepatocellular carcinoma.
    Zindy P; Andrieux L; Bonnier D; Musso O; Langouët S; Campion JP; Turlin B; Clément B; Théret N
    FEBS Lett; 2005 Jan; 579(1):95-9. PubMed ID: 15620696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular profiling of hepatocellular carcinomas (HCC) using a large-scale real-time RT-PCR approach: determination of a molecular diagnostic index.
    Paradis V; Bièche I; Dargère D; Laurendeau I; Laurent C; Bioulac Sage P; Degott C; Belghiti J; Vidaud M; Bedossa P
    Am J Pathol; 2003 Aug; 163(2):733-41. PubMed ID: 12875992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma.
    Chuma M; Sakamoto M; Yamazaki K; Ohta T; Ohki M; Asaka M; Hirohashi S
    Hepatology; 2003 Jan; 37(1):198-207. PubMed ID: 12500205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma.
    Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N
    J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma.
    Kim YD; Park CH; Kim HS; Choi SK; Rew JS; Kim DY; Koh YS; Jeung KW; Lee KH; Lee JS; Juhng SW; Lee JH
    J Gastroenterol Hepatol; 2008 Jan; 23(1):110-8. PubMed ID: 18171349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of vanilloid receptor-1 is associated with better prognosis of patients with hepatocellular carcinoma.
    Miao X; Liu G; Xu X; Xie C; Sun F; Yang Y; Zhang T; Hua S; Fan W; Li Q; Huang S; Wang Q; Liu G; Zhong D
    Cancer Genet Cytogenet; 2008 Oct; 186(1):25-32. PubMed ID: 18786439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
    Yoon SY; Kim JM; Oh JH; Jeon YJ; Lee DS; Kim JH; Choi JY; Ahn BM; Kim S; Yoo HS; Kim YS; Kim NS
    Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of contactin associated protein-like 2 in a subset of hepatic progenitor cell compartment identified by gene expression profiling in hepatitis B virus-positive cirrhosis.
    Wang H; Gao Y; Jin X; Xiao J
    Liver Int; 2010 Jan; 30(1):126-38. PubMed ID: 19889080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
    Perugorria MJ; Castillo J; Latasa MU; Goñi S; Segura V; Sangro B; Prieto J; Avila MA; Berasain C
    Cancer Res; 2009 Feb; 69(4):1358-67. PubMed ID: 19190340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between point mutation and abnormal expression of c-fms oncogene in hepatocellular carcinoma.
    Yang DH; Huang W; Cui J; Shu JC; Tang SH; Zhang WJ; Liang JH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):86-9. PubMed ID: 14969845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [p16 and cyclinD1 protein expression and p16 gene mutation in primary human hepatocellular carcinoma].
    Huang GX; Cheng RX; Feng DY
    Hunan Yi Ke Da Xue Xue Bao; 2001 Dec; 26(6):527-30. PubMed ID: 12536530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GADD45-alpha expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation.
    Gramantieri L; Chieco P; Giovannini C; Lacchini M; Treré D; Grazi GL; Venturi A; Bolondi L
    Hum Pathol; 2005 Nov; 36(11):1154-62. PubMed ID: 16260267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
    Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
    Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Common transcriptional signature of tumor-infiltrating mononuclear inflammatory cells and peripheral blood mononuclear cells in hepatocellular carcinoma patients.
    Sakai Y; Honda M; Fujinaga H; Tatsumi I; Mizukoshi E; Nakamoto Y; Kaneko S
    Cancer Res; 2008 Dec; 68(24):10267-79. PubMed ID: 19074895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kruppel-like factor 6 (KLF6) affects the promoter activity of the alpha1-proteinase inhibitor gene.
    Chiambaretta F; Nakamura H; De Graeve F; Sakai H; Marceau G; Maruyama Y; Rigal D; Dastugue B; Sugar J; Yue BY; Sapin V
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):582-90. PubMed ID: 16431954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma.
    Takashima H; Nakajima T; Moriguchi M; Sekoguchi S; Nishikawa T; Watanabe T; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T
    Liver Int; 2005 Feb; 25(1):77-84. PubMed ID: 15698402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression.
    Breuhahn K; Vreden S; Haddad R; Beckebaum S; Stippel D; Flemming P; Nussbaum T; Caselmann WH; Haab BB; Schirmacher P
    Cancer Res; 2004 Sep; 64(17):6058-64. PubMed ID: 15342387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.
    Murakami Y; Yasuda T; Saigo K; Urashima T; Toyoda H; Okanoue T; Shimotohno K
    Oncogene; 2006 Apr; 25(17):2537-45. PubMed ID: 16331254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.